Product
ASC61
1 clinical trial
1 indication
Indication
CancerClinical trial
An Open-Label, Multicenter, Single-Arm Phase 1 Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61 in Subjects With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2024-12-20